Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.
about
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerFixed erythrodysaesthesia plaque due to intravenous injection of docetaxelA phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumorsDoceaqualip in a patient with prostate cancer who had an allergic reaction to conventional docetaxel: A case reportDocetaxel-induced mitotic arrest in epithelium of gallbladder: a hitherto unreported occurrence.The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cells.Construction and cellular uptake evaluation of redox-responsive docetaxel prodrug self-assembled nanoparticles.Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
P2860
Q28350903-1C07C23C-719A-4E21-A2DE-FB1BC39D65ADQ28378187-067835CF-72F8-4165-B8B6-A5DC955BD405Q33180637-51955B61-0A32-457B-9830-302D74345C26Q36295002-DBBDC903-A671-4218-890E-B5F3E0BF1607Q36816522-1330F0E5-9EBC-4C99-8D04-65513207AF8DQ42183155-0F52D0DD-7AA7-4599-B28C-44400A95ED78Q46082945-04B763C7-8B7B-4F52-9A8E-226072B067F7Q46364014-C1102B1D-60AD-489C-8EE9-37092E4A6A7BQ50204412-F918640E-2802-4111-82B9-A38082ECD607Q59019514-D01FECCE-31F8-4C45-838F-B1CBB842F69A
P2860
Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@ast
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@en
type
label
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@ast
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@en
prefLabel
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@ast
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@en
P2093
P1476
Docetaxel (Taxotere): single a ...... ent and reducing side-effects.
@en
P2093
P304
P356
10.1016/0305-7372(95)90030-6
P577
1995-09-01T00:00:00Z